Safety and Effectiveness of PRI-724 for Hepatitis C or B Virus Derived Liver Cirrhosis

Conditions:   Hepatitis C;   Hepatitis B;   Liver Cirrhoses Intervention:   Drug: PRI-724 Sponsors:   Komagome Hospital;   Prism Pharma Co., Ltd.;   Kyushu University;   National Center for Global Health and Medicine, Japan;   Japan Agency for Medical Research and Development Recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials